Epstein Secrets

ccount You can receive Independent Third Party research on certain companies covered in CSFB's research reports, at no cost to you. You can access this Independent Research, if available from our designated providers, at (www.csfb.com/ir) or b calling (1 ) or emailing ( ) to request a copy of this research. CREDIT

36FY0 FROM 746FY0 S/D FINANCING RETURN FROM 746FY0 TO 2F8EE0 S/D FINANCING FROM 2F8EE0 TO 746FY0 FUNDS RECEIVED BY WIRE -2,000,000 AMGEN INC NT ZER CV 32 03/01/2032 OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 9,740 AMGEN OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 2,000,000 AMGEN INC NT Z

ccount You can receive Independent Third Party research on certain companies covered in CSSU's research reports, at no cost to you. You can access this Independent Research, if available from our designated providers, at (www.credit-suisse.com/ir) or by calling (1 877 291 2683) or emailing (equity.research@credit-suis

01 09/22 JOURNAL 03 09/22 JOURNAL 03 09/22 JOURNAL 03 09/22 BOUGHT 01 09/22 SOLD 03 09/22 BOUGHT QUANTITY DESCRIPTION 2,000,000 AMGEN INC NT ZER CV 32 03/01/2032 OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 -1,060 AMGEN OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 -1,245 MASCO CORP OFFS

ccount You can receive Independent Third Party research on certain companies covered in CSFB's research reports, at no cost to you. You can access this Independent Research, if available from our designated providers, at (www.csfb.com/ir) or by calling (1 877 291 2683) or emailing ([email protected]) to request

ld PROVIDER:Standard & Poor's ALLERGAN INC SR NT CV ZERO 22 11/06/2022 AMERICAN FINL GROUP INC OHIO SR 01.4861 06/02/2033 NT CV1. AMGEN INC NT ZER CV 32 AMYLIN PHARMACEUTICALS INC NT CV 2 BARNES GROUP INC CVT 144A CBRL GROUP INC EFTA01593609 03/01/2032 SR 02.5000 04/15/2011 03.7500 08/01/

ccount You can receive Independent Third Party research on certain companies covered in CSFB's research reports, at no cost to you. You can access this Independent Research, if available from our designated providers, at (www.csfb.com/ir) or b calling (1 ) or emailing ( ) to request a copy of this research. Rating

0 2,000,000 125,000 1,075,000 :NEUTRAL INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor's ALLERGAN INC SR NT CV ZERO 22 AMGEN INC NT ZER CV 32 11/06/2022 03/01/2032 AMYLIN PHARMACEUTICALS INC NT CV 2 BARNES GROUP INC CVT 144A CBRL GROUP INC SR 02.5000 04/15/2011 EFTA01593661 03

ccount You can receive Independent Third Party research on certain companies covered in CSFB's research reports, at no cost to you. You can access this Independent Research, if available from our designated providers, at (www.csfb.com/ir) or by calling (1 877 291 2683) or emailing ([email protected]) to request

M 746FY0 MARK TO MARKET MARK TO MARKET FUNDS PAID BY WIRE WIRE TO CITIBANK MARK TO MARKET MARK TO MARKET EFTA01593439 2,000,000 AMGEN INC NT ZER CV 32 03/01/2032 OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 276,532.98 7,658.00 276,532.98 179,941.42 1,584,660.00 11,000.00 66,798.77 66,

ccount You can receive Independent Third Party research on certain companies covered in CSSU's research reports, at no cost to you. You can access this Independent Research, if available from our designated providers, at (www.credit-suisse.com/ir) or by calling (1 877 291 2683) or emailing (equity.research@credit-suis

00 2,250,000 125,000 1,052,000 75,000 1,600,000 9,965 (S) UNISOURCE ENERGY CORP HLDG CO AMERICAN FINL GROUP INC OHIO SR NT CV1. AMGEN INC NT ZER CV 32 CBRL GROUP INC EFTA01593835 01.4861 06/02/2033 03/01/2032 04/03/2032 LYON ZERO 32 CMS ENERGY CORP SR NT-B CV 23 CSX CORP BOND CVT CELGEN

ccount You can receive Independent Third Party research on certain companies covered in CSSU's research reports, at no cost to you. You can access this Independent Research, if available from our designated providers, at (www.credit-suisse.com/ir) or by calling (1 877 291 2683) or emailing (equity.research@credit-suis

Securities 97.55000 INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor's AMERICAN FINL GROUP INC OHIO SR 01.4861 06/02/2033 AMGEN INC NT ZER CV 32 CBRL GROUP INC CSX CORP BOND CVT CELGENE CORP CVT EFTA01593969 01.7500 06/01/2008 CENTERPOINT ENERGY INC CVT SER B 03.7500 05/15/2023 CHE

ccount You can receive Independent Third Party research on certain companies covered in CSSU's research reports, at no cost to you. You can access this Independent Research, if available from our designated providers, at (www.credit-suisse.com/ir) or b calling (1 ) or emailing ( ) to request a copy of this research

FY0 FROM 746FY0 EFTA01593920 MARK TO MARKET MARK TO MARKET MARK TO MARKET FUNDS PAID BY WIRE WIRE TO CITIBANK FUT MGN -2,000,000 AMGEN INC NT ZER CV 32 03/01/2032 OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 1,488,750.00 121,404.15 11,243.00 68,429.83 35,460.62 5,778.00 35,460.62 42,53

ccount You can receive Independent Third Party research on certain companies covered in CSSU's research reports, at no cost to you. You can access this Independent Research, if available from our designated providers, at (www.credit-suisse.com/ir) or b calling (1 ) or emailing ( ) to request a copy of this research

,600,000 4,000,000 3,000,000 ALLERGAN INC SR NT CV ZERO 22 11/06/2022 AMERICAN FINL GROUP INC OHIO SR 01.4861 06/02/2033 NT CV1. AMGEN INC NT ZER CV 32 CBRL GROUP INC CSX CORP BOND CVT CELGENE CORP CVT 01.7500 06/01/2008 CENTERPOINT ENERGY INC CVT SER B 03.7500 05/15/2023 EFTA01594051 CHE